Perez, E E <br/><br/>
Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients.  [electronic resource] 

 -  The Journal of infectious diseases  Feb 2001 
 - 579-88 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1899 
<br/><br/><label>Standard No.: </label>10.1086/318538  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Amino Acid Substitution<br/>Anti-HIV Agents--therapeutic use<br/>Child<br/>Child, Preschool<br/>Cohort Studies<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>HIV Infections--drug therapy<br/>HIV Protease--genetics<br/>HIV Reverse Transcriptase--genetics<br/>HIV-1--enzymology<br/>Humans<br/>Infant<br/>Male<br/>Phylogeny<br/>Predictive Value of Tests<br/>Prospective Studies<br/>Reverse Transcriptase Inhibitors--therapeutic use<br/>Sequence Analysis, DNA<br/>Treatment Outcome